Cypre Presents Solution for High-Throughput Screening Using 3D Culture at SLAS 2019

In a poster titled “A novel high-throughput solution for screening drugs with a light-crosslinked VersaGel 3D tumor culture model and automated high-content imaging” Cypre and Molecular Devices co-presented data at SLAS 2019.

Here is Cypre CEO Kolin Hribar, PhD. discussing the poster.

Use the form below to request a copy of the poster.

Robert Lynde